Ly6Clo monocytes drive immunosuppression and confer resistance to anti-VEGFR2 cancer therapy. (Q42644178)
Jump to navigation
Jump to search
scientific article published on 10 July 2017
Language | Label | Description | Also known as |
---|---|---|---|
English | Ly6Clo monocytes drive immunosuppression and confer resistance to anti-VEGFR2 cancer therapy. |
scientific article published on 10 July 2017 |
Statements
Ly6Clo monocytes drive immunosuppression and confer resistance to anti-VEGFR2 cancer therapy (English)
Robert Langer
Rakesh K Jain
Timothy P Padera
Keehoon Jung
Takahiro Heishi
Joao Incio
Dai Fukumura
Omar F Khan
Nuh N Rahbari
Jeffrey W Clark
Christopher G Willett
Andrew D Luster
Seok Hyun Yun
Daniel G Anderson